1. Home
  2. Stocks
  3. Par Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Par Drugs & Chemicals Share Price Par Drugs & Chemicals

    Small Cap
    ₹278.6
    +6.95 (2.56%)
    20 April, 2024 01:17 BSE: NSE: PARISIN: INE04LG01015
    Bonus

    Start SIP in Par Drugs & Chemicals

    Start SIP

    Par Drugs & Chemicals Performance

    Day Range

    • Low 266
    • High 325
    ₹ 278

    52 Week Range

    • Low 162
    • High 325
    ₹ 278
    • Open Price268
    • Previous Close272
    • Volume1672082

    Par Drugs & Chemicals Share Price

    • Over 1 Month +33.62%
    • Over 3 Month +34.72%
    • Over 6 Month +38.5%
    • Over 1 Year +77.34%

    Par Drugs & Chemicals Key Statistics

    P/E Ratio 24.1
    PEG Ratio 0.6
    Market Cap Cr 343
    Price to Book Ratio 4.8
    EPS 9.1
    Dividend 0
    Relative Strength Index 74.54
    Money Flow Index 96.86
    MACD Signal 11.12
    Average True Range 19.6
    Par Drugs & Chemicals Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 24262324
    Operating Expenses Qtr Cr 19191919
    Operating Profit Qtr Cr 5745
    Depreciation Qtr Cr 1111
    Interest Qtr Cr 0000
    Tax Qtr Cr 1211
    Net Profit Qtr Cr 3523
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 96
    Operating Expenses Annual Cr 78
    Operating Profit Annual in Cr 18
    Depreciation Cr 3
    Interest Annual Cr 0
    Tax Annual Cr 4
    Net Profit Annual Cr 11
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 13
    Cash from Investing Activity Annual Cr -7
    Cash from Financing Annual Activity Cr 0
    Net Cash Flow Annual Cr 6
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 71
    Fixed Assets Annual Cr 39
    Total Non Current Assets Annual Cr 39
    Total Current Assets Annual Cr 49
    Total Assets Annual Cr 89
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 58
    ROE Annual % 16
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 19
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin %
    Sign Up to Know More
    Invest in Par Drugs & Chemicals

    Par Drugs & Chemicals Technicals

    EMA & SMA

    Current Price
    ₹278.6
    +6.95 (2.56%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹242.34
    • 50 Day
    • ₹226.15
    • 100 Day
    • ₹218.15
    • 200 Day
    • ₹208.22
    • 20 Day
    • ₹234.99
    • 50 Day
    • ₹219.27
    • 100 Day
    • ₹216.89
    • 200 Day
    • ₹208.52

    Par Drugs & Chemicals Resistance and Support

    PIVOT
    ₹289.87
    Resistance
    First Resistance 313.73
    Second Resistance 348.87
    Third Resistance 372.73
    RSI 74.54
    MFI 96.86
    MACD Single Line 11.12
    MACD 16.30
    Support
    First Resistance 254.73
    Second Resistance 230.87
    Third Resistance 195.73

    Par Drugs & Chemicals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 1,672,082 27,489,028 16.44
    Week 721,502 13,080,836 18.13
    1 Month 215,766 6,121,291 28.37
    6 Month 56,225 2,449,732 43.57

    Par Drugs & Chemicals Result Highlights

    Par Drugs & Chemicals Synopsis

    NSE-Medical-Diversified

    Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 95.75 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2023. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.
    Market Cap 343
    Sales 97
    Shares in Float 0.32
    No of funds
    Yield 0.72
    Book Value 4.75
    U/D Vol ratio 4.3
    LTDebt / Equity
    Alpha 0.21
    Beta 0.42

    Par Drugs & Chemicals

    Owner NameDec-23Sep-23Jun-23
    Promoters 74.21%74.21%74.21%
    Mutual Funds
    Insurance Companies
    Foreign Portfolio Investors 0.07%
    Financial Institutions/ Banks
    Individual Investors 21.23%21.4%21.85%
    Others 4.49%4.39%3.94%

    Par Drugs & Chemicals Management

    Name Designation
    Mr. Falgun Vallabhbhai Savani Chairman & Managing Director
    Mr. Jignesh Vallabhbhai Savani Executive Director & CEO
    Mr. Ghanshayambhai Bhagvanbhai Savani Whole Time Director
    Mrs. Nayna Jignesh Savani Non Executive Director
    Mr. Pravin Manjibhai Bhayani Independent Director
    Mrs. Kajal Chintanbhai Vaghani Independent Director
    Mr. Krishna Mitulbhai Shah Independent Director
    Mrs. Bintal Bhaveshkumar Shah Independent Director

    Par Drugs & Chemicals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Par Drugs & Chemicals Corporate Action

    Date Purpose Remarks
    2024-02-16 Quarterly Results (Revised) issue in the ratio of 1:1 of Rs. 10/-.
    2023-10-28 Quarterly Results
    2023-08-03 Quarterly Results
    2023-04-27 Audited Results
    2023-02-10 Quarterly Results
    Date Purpose Remarks
    2021-04-28 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

    Par Drugs & Chemicals MF Shareholding

    Name Amount(cr)

    Par Drugs & Chemicals FAQs

    What is Share Price of Par Drugs & Chemicals ?

    Par Drugs & Chemicals share price is ₹278 As on 20 April, 2024 | 01:03

    What is the Market Cap of Par Drugs & Chemicals ?

    The Market Cap of Par Drugs & Chemicals is ₹342.8 Cr As on 20 April, 2024 | 01:03

    What is the P/E ratio of Par Drugs & Chemicals ?

    The P/E ratio of Par Drugs & Chemicals is 24.1 As on 20 April, 2024 | 01:03

    What is the PB ratio of Par Drugs & Chemicals ?

    The PB ratio of Par Drugs & Chemicals is 4.8 As on 20 April, 2024 | 01:03

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.